To achieve sufficient glutamine, cancer cells must uptake glutamine from the extracellular environment through specific transporters on the cell membrane, such as the alanine-serine-cysteine transporter 2 (ASCT2), also known as SLCA15 (Scalise et al., 2017). Here, SLC1A5 is linked to cancer.